Literature DB >> 10965062

Nonradioisotope assay of glucose uptake activity in rat skeletal muscle using enzymatic measurement of 2-deoxyglucose 6-phosphate in vitro and in vivo.

A Ueyama1, T Sato, H Yoshida, K Magata, N Koga.   

Abstract

We investigated a nonradioisotope method for the evaluation of glucose uptake activity using enzymatic measurement of 2-deoxyglucose 6-phosphate (2DG6P) content in isolated rat soleus muscle in vitro and in vivo. The 2DG6P content in isolated rat soleus muscle after incubation with 2-deoxyglucose (2DG) was increased in a dose-dependent manner by insulin (ED(50) = 0.6 mU/ml), the maximum response being about 5 times that of the basal content in vitro. This increment was completely abolished by wortmannin (100 nM), with no effect on basal 2DG6P content. An insulin-mimetic compound, vanadium, also increased 2DG6P content in a dose-dependent manner. In isolated soleus muscle of Zucker fa/fa rats, well known as an insulin-resistant model, insulin did not increase 2DG6P content. The 2DG6P content in rat soleus muscle increased after 2DG (3 mmol/kg) injection in vivo, and conversely, the 2DG concentration in plasma was decreased in a dose-dependent manner by insulin (ED(50) = 0.11 U/kg). The maximum response of the accumulation of 2DG6P in soleus muscle was about 4 times that of the basal content. This method could be useful for evaluating glucose uptake (transport plus phosphorylation) activity in soleus muscle in vitro and in vivo without using radioactive materials. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965062     DOI: 10.1159/000014649

Source DB:  PubMed          Journal:  Biol Signals Recept        ISSN: 1422-4933


  8 in total

1.  Elevation of muscle temperature stimulates muscle glucose uptake in vivo and in vitro.

Authors:  Keiichi Koshinaka; Emi Kawamoto; Natsuki Abe; Koji Toshinai; Masamitsu Nakazato; Kentaro Kawanaka
Journal:  J Physiol Sci       Date:  2013-07-09       Impact factor: 2.781

2.  The effect of high-intensity intermittent swimming on post-exercise glycogen supercompensation in rat skeletal muscle.

Authors:  Akiko Sano; Keiichi Koshinaka; Natsuki Abe; Masashi Morifuji; Jinichiro Koga; Emi Kawasaki; Kentaro Kawanaka
Journal:  J Physiol Sci       Date:  2011-10-08       Impact factor: 2.781

3.  Mfge8 promotes obesity by mediating the uptake of dietary fats and serum fatty acids.

Authors:  Amin Khalifeh-Soltani; William McKleroy; Stephen Sakuma; Yuk Yin Cheung; Kevin Tharp; Yifu Qiu; Scott M Turner; Ajay Chawla; Andreas Stahl; Kamran Atabai
Journal:  Nat Med       Date:  2014-01-19       Impact factor: 53.440

4.  Increased postexercise insulin sensitivity is accompanied by increased AS160 phosphorylation in slow-twitch soleus muscle.

Authors:  Maiko Iwabe; Emi Kawamoto; Keiichi Koshinaka; Kentaro Kawanaka
Journal:  Physiol Rep       Date:  2014-12-11

5.  Immobilization rapidly induces muscle insulin resistance together with the activation of MAPKs (JNK and p38) and impairment of AS160 phosphorylation.

Authors:  Emi Kawamoto; Keiichi Koshinaka; Tatsuhiko Yoshimura; Hiroyuki Masuda; Kentaro Kawanaka
Journal:  Physiol Rep       Date:  2016-08

6.  Angiotensin-(1-7) Participates in Enhanced Skeletal Muscle Insulin Sensitivity After a Bout of Exercise.

Authors:  Omar Echeverría-Rodríguez; Itzell A Gallardo-Ortíz; Leonardo Del Valle-Mondragón; Rafael Villalobos-Molina
Journal:  J Endocr Soc       Date:  2020-01-31

7.  The Potential Therapeutic Effect of Orexin-Treated versus Orexin-Untreated Adipose Tissue-Derived Mesenchymal Stem Cell Therapy on Insulin Resistance in Type 2 Diabetic Rats.

Authors:  Amy F Boushra; Rania H Mahmoud; Shymaa E Ayoub; Rehab A Mohammed; Hanan A Shamardl; Amani M El Amin Ali
Journal:  J Diabetes Res       Date:  2022-01-17       Impact factor: 4.011

8.  Glucose enhances catecholamine-stimulated lipolysis via increased glycerol-3-phosphate synthesis in 3T3-L1 adipocytes and rat adipose tissue.

Authors:  Nodoka Takeuchi; Kazuhiko Higashida; Xi Li; Naoya Nakai
Journal:  Mol Biol Rep       Date:  2021-08-10       Impact factor: 2.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.